{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T14:07:38Z","timestamp":1792591658118,"version":"4.5.0"},"reference-count":69,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,5,12]],"date-time":"2018-05-12T00:00:00Z","timestamp":1526083200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clinic Rev Allerg Immunol"],"published-print":{"date-parts":[[2019,2]]},"DOI":"10.1007\/s12016-018-8685-0","type":"journal-article","created":{"date-parts":[[2018,5,12]],"date-time":"2018-05-12T19:32:55Z","timestamp":1526153575000},"page":"1-8","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":69,"title":["The Unique Molecular Signatures of Contact Dermatitis and Implications for Treatment"],"prefix":"10.1007","volume":"56","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7680-0598","authenticated-orcid":false,"given":"Alexandra","family":"Leonard","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emma","family":"Guttman-Yassky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,5,12]]},"reference":[{"issue":"5","key":"8685_CR1","first-page":"284","volume":"14","author":"P Saint-Mezard","year":"2004","unstructured":"Saint-Mezard P, Rosieres A, Krasteva M, Berard F, Dubois B, Kaiserlian D, Nicolas JF (2004) Allergic contact dermatitis. Eur J Dermatol: EJD 14(5):284\u2013295","journal-title":"Eur J Dermatol: EJD"},{"issue":"3","key":"8685_CR2","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1097\/DER.0000000000000278","volume":"28","author":"B Zack","year":"2017","unstructured":"Zack B, Arrandale VH, Holness DL (2017) Preventing occupational skin disease: a review of training programs. Dermat : Contact, Atopic, Occup, Drug 28(3):169\u2013182","journal-title":"Dermat : Contact, Atopic, Occup, Drug"},{"issue":"2","key":"8685_CR3","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1111\/j.1600-0536.2009.01669.x","volume":"62","author":"JP Thyssen","year":"2010","unstructured":"Thyssen JP, Johansen JD, Linneberg A, Menne T (2010) The epidemiology of hand eczema in the general population--prevalence and main findings. Contact Dermat 62(2):75\u201387","journal-title":"Contact Dermat"},{"key":"8685_CR4","doi-asserted-by":"crossref","unstructured":"Eckert L, Gupta S, Amand C, Gadkari A, Mahajan P, Gelfand JM (2017) The burden of atopic dermatitis in US adults: health care resource utilization data from the 2013 National Health and Wellness Survey. J Am Acad Dermatol","DOI":"10.1016\/j.jaad.2017.08.002"},{"issue":"10023","key":"8685_CR5","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1016\/S0140-6736(15)00149-X","volume":"387","author":"S Weidinger","year":"2016","unstructured":"Weidinger S, Novak N (2016) Atopic dermatitis. Lancet (London, England) 387(10023):1109\u20131122","journal-title":"Lancet (London, England)"},{"issue":"5","key":"8685_CR6","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1007\/s00420-002-0419-0","volume":"76","author":"AL Chew","year":"2003","unstructured":"Chew AL, Maibach HI (2003) Occupational issues of irritant contact dermatitis. Int Arch Occup Environ Health 76(5):339\u2013346","journal-title":"Int Arch Occup Environ Health"},{"issue":"2","key":"8685_CR7","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1016\/j.jaci.2012.06.048","volume":"131","author":"JK Gittler","year":"2013","unstructured":"Gittler JK, Krueger JG, Guttman-Yassky E (2013) Atopic dermatitis results in intrinsic barrier and immune abnormalities: implications for contact dermatitis. J Allergy Clin Immunol 131(2):300\u2013313","journal-title":"J Allergy Clin Immunol"},{"issue":"3","key":"8685_CR8","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1016\/j.det.2009.05.002","volume":"27","author":"SC Clark","year":"2009","unstructured":"Clark SC, Zirwas MJ (2009) Management of occupational dermatitis. Dermatol Clin 27(3):365\u2013383 vii-viii","journal-title":"Dermatol Clin"},{"issue":"4","key":"8685_CR9","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1684\/ejd.2009.0686","volume":"19","author":"A Nosbaum","year":"2009","unstructured":"Nosbaum A, Vocanson M, Rozieres A, Hennino A, Nicolas JF (2009) Allergic and irritant contact dermatitis. Eur J Dermatol: EJD. 19(4):325\u2013332","journal-title":"Eur J Dermatol: EJD."},{"issue":"6","key":"8685_CR10","doi-asserted-by":"publisher","first-page":"1430","DOI":"10.1038\/sj.jid.5700726","volume":"127","author":"M Bonneville","year":"2007","unstructured":"Bonneville M, Chavagnac C, Vocanson M, Rozieres A, Benetiere J, Pernet I, Denis A, Nicolas JF, Hennino A (2007) Skin contact irritation conditions the development and severity of allergic contact dermatitis. J Investig Dermatol 127(6):1430\u20131435","journal-title":"J Investig Dermatol"},{"issue":"12","key":"8685_CR11","doi-asserted-by":"publisher","first-page":"1699","DOI":"10.1111\/j.1398-9995.2009.02082.x","volume":"64","author":"M Vocanson","year":"2009","unstructured":"Vocanson M, Hennino A, Rozieres A, Poyet G, Nicolas JF (2009) Effector and regulatory mechanisms in allergic contact dermatitis. Allergy 64(12):1699\u20131714","journal-title":"Allergy"},{"issue":"1","key":"8685_CR12","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1007\/s00403-011-1168-2","volume":"304","author":"SC DaSilva","year":"2012","unstructured":"DaSilva SC, Sahu RP, Konger RL, Perkins SM, Kaplan MH, Travers JB (2012) Increased skin barrier disruption by sodium lauryl sulfate in mice expressing a constitutively active STAT6 in T cells. Arch Dermatol Res 304(1):65\u201371","journal-title":"Arch Dermatol Res"},{"issue":"1","key":"8685_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/cod.12789","volume":"77","author":"SA Koppes","year":"2017","unstructured":"Koppes SA, Engebretsen KA, Agner T, Angelova-Fischer I, Berents T, Brandner J, Brans R, Clausen ML, Hummler E, Jakasa I, Juraki\u0107-Ton\u010dic R, John SM, Khnykin D, Molin S, Holm JO, Suomela S, Thierse HJ, Kezic S, Martin SF, Thyssen JP (2017) Current knowledge on biomarkers for contact sensitization and allergic contact dermatitis. Contact Dermat 77(1):1\u201316","journal-title":"Contact Dermat"},{"issue":"4","key":"8685_CR14","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1111\/j.1600-0536.2011.02045.x","volume":"66","author":"L Landeck","year":"2012","unstructured":"Landeck L, Visser M, Kezic S, John SM (2012) Impact of tumour necrosis factor-alpha polymorphisms on irritant contact dermatitis. Contact Dermat 66(4):221\u2013227","journal-title":"Contact Dermat"},{"issue":"3","key":"8685_CR15","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1007\/s002510050032","volume":"51","author":"MH Allen","year":"2000","unstructured":"Allen MH, Wakelin SH, Holloway D, Lisby S, Baadsgaard O, Barker JN et al (2000) Association of TNFA gene polymorphism at position -308 with susceptibility to irritant contact dermatitis. Immunogenetics 51(3):201\u2013205","journal-title":"Immunogenetics"},{"issue":"5","key":"8685_CR16","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1111\/j.1600-0536.2008.01317.x","volume":"58","author":"CM Jongh de","year":"2008","unstructured":"de Jongh CM, John SM, Bruynzeel DP, Calkoen F, van Dijk FJ, Khrenova L et al (2008) Cytokine gene polymorphisms and susceptibility to chronic irritant contact dermatitis. Contact Dermat 58(5):269\u2013277","journal-title":"Contact Dermat"},{"issue":"2","key":"8685_CR17","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1016\/j.jaci.2014.03.009","volume":"134","author":"N Dhingra","year":"2014","unstructured":"Dhingra N, Shemer A, Correa da Rosa J, Rozenblit M, Fuentes-Duculan J, Gittler JK, Finney R, Czarnowicki T, Zheng X, Xu H, Estrada YD, Cardinale I, Su\u00e1rez-Fari\u00f1as M, Krueger JG, Guttman-Yassky E (2014) Molecular profiling of contact dermatitis skin identifies allergen-dependent differences in immune response. J Allergy Clin Immunol 134(2):362\u2013372","journal-title":"J Allergy Clin Immunol"},{"issue":"4","key":"8685_CR18","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1097\/ACI.0b013e3283088cf9","volume":"8","author":"SF Martin","year":"2008","unstructured":"Martin SF, Jakob T (2008) From innate to adaptive immune responses in contact hypersensitivity. Curr Opin Allergy Clin Immunol 8(4):289\u2013293","journal-title":"Curr Opin Allergy Clin Immunol"},{"key":"8685_CR19","first-page":"41","volume":"104","author":"HU Weltzien","year":"2014","unstructured":"Weltzien HU, Martin SF, Nicolas JF (2014) T cell responses to contact allergens. EXS 104:41\u201349","journal-title":"EXS"},{"issue":"2","key":"8685_CR20","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/0300-483X(95)03253-C","volume":"107","author":"HU Weltzien","year":"1996","unstructured":"Weltzien HU, Moulon C, Martin S, Padovan E, Hartmann U, Kohler J (1996) T cell immune responses to haptens. Structural models for allergic and autoimmune reactions. Toxicology 107(2):141\u2013151","journal-title":"Toxicology"},{"issue":"6","key":"8685_CR21","doi-asserted-by":"publisher","first-page":"2974","DOI":"10.4049\/jimmunol.0803478","volume":"184","author":"RP Larson","year":"2010","unstructured":"Larson RP, Zimmerli SC, Comeau MR, Itano A, Omori M, Iseki M, Hauser C, Ziegler SF (2010) Dibutyl phthalate-induced thymic stromal lymphopoietin is required for Th2 contact hypersensitivity responses. J Immunol 184(6):2974\u20132984","journal-title":"J Immunol"},{"issue":"4","key":"8685_CR22","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1038\/sj.jid.5700174","volume":"126","author":"M Vocanson","year":"2006","unstructured":"Vocanson M, Hennino A, Cluzel-Tailhardat M, Saint-Mezard P, Benetiere J, Chavagnac C, Berard F, Kaiserlian D, Nicolas JF (2006) CD8+ T cells are effector cells of contact dermatitis to common skin allergens in mice. J Investig Dermatol. 126(4):815\u2013820","journal-title":"J Investig Dermatol."},{"issue":"4","key":"8685_CR23","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1046\/j.1523-1747.2003.12093.x","volume":"120","author":"P Saint-Mezard","year":"2003","unstructured":"Saint-Mezard P, Krasteva M, Chavagnac C, Bosset S, Akiba H, Kehren J, Nicolas JF, Berard F, Kanitakis J, Kaiserlian D (2003) Afferent and efferent phases of allergic contact dermatitis (ACD) can be induced after a single skin contact with haptens: evidence using a mouse model of primary ACD. J Investig Dermatol. 120(4):641\u2013647","journal-title":"J Investig Dermatol."},{"issue":"2","key":"8685_CR24","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1016\/j.jaad.2013.03.012","volume":"69","author":"D Malajian","year":"2013","unstructured":"Malajian D, Belsito DV (2013) Cutaneous delayed-type hypersensitivity in patients with atopic dermatitis. J Am Acad Dermatol 69(2):232\u2013237","journal-title":"J Am Acad Dermatol"},{"issue":"10","key":"8685_CR25","doi-asserted-by":"publisher","first-page":"2372","DOI":"10.1038\/jid.2013.148","volume":"133","author":"L Newell","year":"2013","unstructured":"Newell L, Polak ME, Perera J, Owen C, Boyd P, Pickard C, Howarth PH, Healy E, Holloway JW, Friedmann PS, Ardern-Jones MR (2013) Sensitization via healthy skin programs Th2 responses in individuals with atopic dermatitis. J Investig Dermatol. 133(10):2372\u20132380","journal-title":"J Investig Dermatol."},{"issue":"3","key":"8685_CR26","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1016\/j.jaci.2014.11.017","volume":"135","author":"J Correa da Rosa","year":"2015","unstructured":"Correa da Rosa J, Malajian D, Shemer A, Rozenblit M, Dhingra N, Czarnowicki T, Khattri S, Ungar B, Finney R, Xu H, Zheng X, Estrada YD, Peng X, Su\u00e1rez-Fari\u00f1as M, Krueger JG, Guttman-Yassky E (2015) Patients with atopic dermatitis have attenuated and distinct contact hypersensitivity responses to common allergens in skin. J Allergy Clin Immunol 135(3):712\u2013720","journal-title":"J Allergy Clin Immunol"},{"issue":"3","key":"8685_CR27","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1111\/exd.13148","volume":"26","author":"B Ungar","year":"2017","unstructured":"Ungar B, Correa da Rosa J, Shemer A, Czarnowicki T, Estrada YD, Fuentes-Duculan J, Xu H, Zheng X, Peng X, Su\u00e1rez-Fari\u00f1as M, Nowak-Wegrzyn A, Sampson HA, Krueger JG, Guttman-Yassky E (2017) Patch testing of food allergens promotes Th17 and Th2 responses with increased IL-33: a pilot study. Exp Dermatol 26(3):272\u2013275","journal-title":"Exp Dermatol"},{"issue":"11","key":"8685_CR28","doi-asserted-by":"publisher","first-page":"4965","DOI":"10.1172\/JCI75660","volume":"124","author":"L Tordesillas","year":"2014","unstructured":"Tordesillas L, Goswami R, Benede S, Grishina G, Dunkin D, Jarvinen KM et al (2014) Skin exposure promotes a Th2-dependent sensitization to peanut allergens. J Clin Invest 124(11):4965\u20134975","journal-title":"J Clin Invest"},{"key":"8685_CR29","doi-asserted-by":"crossref","unstructured":"Malik K, Ungar B, Garcet S, Dutt R, Dickstein D, Zheng X, et al. 2017 Dust mite induces multiple polar T-cell axes in human skin. Clinical and experimental allergy: journal of the British Society for Allergy and Clin Immunol","DOI":"10.1111\/cea.13040"},{"issue":"2","key":"8685_CR30","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1038\/nri3150","volume":"12","author":"DH Kaplan","year":"2012","unstructured":"Kaplan DH, Igyarto BZ, Gaspari AA (2012) Early immune events in the induction of allergic contact dermatitis. Nat Rev Immunol 12(2):114\u2013124","journal-title":"Nat Rev Immunol"},{"issue":"2","key":"8685_CR31","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1038\/jid.2012.284","volume":"133","author":"T Honda","year":"2013","unstructured":"Honda T, Egawa G, Grabbe S, Kabashima K (2013) Update of immune events in the murine contact hypersensitivity model: toward the understanding of allergic contact dermatitis. J Investig Dermatol. 133(2):303\u2013315","journal-title":"J Investig Dermatol."},{"key":"8685_CR32","doi-asserted-by":"publisher","DOI":"10.1155\/2013\/261037","volume":"2013","author":"M Peiser","year":"2013","unstructured":"Peiser M (2013) Role of Th17 cells in skin inflammation of allergic contact dermatitis. Clin Dev Immunol 2013:261037","journal-title":"Clin Dev Immunol"},{"key":"8685_CR33","doi-asserted-by":"crossref","unstructured":"Zug KA, Warshaw EM, Fowler JF, Jr., Maibach HI, Belsito DL, Pratt MD, et al. Patch-test results of the North American Contact Dermatitis Group 2005-2006. Dermat : Contact, Atopic, Occup, Drug. 2009;20(3):149\u2013160","DOI":"10.2310\/6620.2009.08097"},{"issue":"4","key":"8685_CR34","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1016\/j.jaci.2010.12.1124","volume":"127","author":"M Suarez-Farinas","year":"2011","unstructured":"Suarez-Farinas M, Tintle SJ, Shemer A, Chiricozzi A, Nograles K, Cardinale I et al (2011) Nonlesional atopic dermatitis skin is characterized by broad terminal differentiation defects and variable immune abnormalities. J Allergy Clin Immunol 127(4):954\u201364.e1\u20134","journal-title":"J Allergy Clin Immunol"},{"issue":"4","key":"8685_CR35","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1016\/j.jaip.2014.03.006","volume":"2","author":"T Czarnowicki","year":"2014","unstructured":"Czarnowicki T, Krueger JG, Guttman-Yassky E (2014) Skin barrier and immune dysregulation in atopic dermatitis: an evolving story with important clinical implications. J Allergy Clin Immunol Pract 2(4):371\u2013379 quiz 80-1","journal-title":"J Allergy Clin Immunol Pract"},{"key":"8685_CR36","doi-asserted-by":"publisher","first-page":"2017","DOI":"10.1111\/all.13223","volume":"72","author":"PM Brunner","year":"2017","unstructured":"Brunner PM, Emerson RO, Tipton C, Garcet S, Khattri S, Coats I, Krueger JG, Guttman-Yassky E (2017) Nonlesional atopic dermatitis skin shares similar T-cell clones with lesional tissues. Allergy 72:2017\u20132025","journal-title":"Allergy"},{"key":"8685_CR37","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.coi.2017.08.008","volume":"48","author":"E Guttman-Yassky","year":"2017","unstructured":"Guttman-Yassky E, Krueger JG (2017) Atopic dermatitis and psoriasis: two different immune diseases or one spectrum? Curr Opin Immunol 48:68\u201373","journal-title":"Curr Opin Immunol"},{"issue":"1","key":"8685_CR38","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.jid.2016.08.022","volume":"137","author":"PM Brunner","year":"2017","unstructured":"Brunner PM, Silverberg JI, Guttman-Yassky E, Paller AS, Kabashima K, Amagai M, Luger TA, Deleuran M, Werfel T, Eyerich K, Stingl G, Bagot M, Hijnen DJ, Ardern-Jones M, Reynolds N, Spuls P, Taieb A (2017) Increasing comorbidities suggest that atopic dermatitis is a systemic disorder. J Investig Dermatol. 137(1):18\u201325","journal-title":"J Investig Dermatol."},{"issue":"4","key":"8685_CR39","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1038\/nrm1619","volume":"6","author":"E Candi","year":"2005","unstructured":"Candi E, Schmidt R, Melino G (2005) The cornified envelope: a model of cell death in the skin. Nat Rev Mol Cell Biol 6(4):328\u2013340","journal-title":"Nat Rev Mol Cell Biol"},{"key":"8685_CR40","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.coi.2016.05.002","volume":"42","author":"B Cabanillas","year":"2016","unstructured":"Cabanillas B, Novak N (2016) Atopic dermatitis and filaggrin. Curr Opin Immunol 42:1\u20138","journal-title":"Curr Opin Immunol"},{"key":"8685_CR41","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1186\/s13223-016-0158-5","volume":"12","author":"L Bin","year":"2016","unstructured":"Bin L, Leung DY (2016) Genetic and epigenetic studies of atopic dermatitis. Allergy, Asthma, Clin Immunol : Off J Can Soc Allergy Clin Immunol 12:52","journal-title":"Allergy, Asthma, Clin Immunol : Off J Can Soc Allergy Clin Immunol"},{"issue":"3 Suppl 2","key":"8685_CR42","doi-asserted-by":"publisher","first-page":"R7","DOI":"10.1016\/j.jaci.2009.07.012","volume":"124","author":"MD Howell","year":"2009","unstructured":"Howell MD, Kim BE, Gao P, Grant AV, Boguniewicz M, DeBenedetto A, Schneider L, Beck LA, Barnes KC, Leung DYM (2009) Cytokine modulation of atopic dermatitis filaggrin skin expression. J Allergy Clin Immunol 124(3 Suppl 2):R7\u2013r12","journal-title":"J Allergy Clin Immunol"},{"key":"8685_CR43","first-page":"60","volume":"8","author":"DA Ewald","year":"2015","unstructured":"Ewald DA, Malajian D, Krueger JG, Workman CT, Wang T, Tian S, Litman T, Guttman-Yassky E, Su\u00e1rez-Fari\u00f1as M (2015) Meta-analysis derived atopic dermatitis (MADAD) transcriptome defines a robust AD signature highlighting the involvement of atherosclerosis and lipid metabolism pathways. BMC Med Genet 8:60","journal-title":"BMC Med Genet"},{"issue":"1","key":"8685_CR44","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.jdermsci.2017.05.005","volume":"88","author":"M Danso","year":"2017","unstructured":"Danso M, Boiten W, van Drongelen V, Gmelig Meijling K, Gooris G, El Ghalbzouri A et al (2017) Altered expression of epidermal lipid bio-synthesis enzymes in atopic dermatitis skin is accompanied by changes in stratum corneum lipid composition. J Dermatol Sci 88(1):57\u201366","journal-title":"J Dermatol Sci"},{"issue":"1","key":"8685_CR45","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1046\/j.1523-1747.2003.12323.x","volume":"121","author":"H Dickel","year":"2003","unstructured":"Dickel H, Bruckner TM, Schmidt A, Diepgen TL (2003) Impact of atopic skin diathesis on occupational skin disease incidence in a working population. J Investig Dermatol. 121(1):37\u201340","journal-title":"J Investig Dermatol."},{"issue":"10","key":"8685_CR46","doi-asserted-by":"publisher","first-page":"2311","DOI":"10.1038\/jid.2013.239","volume":"133","author":"N Dhingra","year":"2013","unstructured":"Dhingra N, Gulati N, Guttman-Yassky E (2013) Mechanisms of contact sensitization offer insights into the role of barrier defects vs. intrinsic immune abnormalities as drivers of atopic dermatitis. J Investig Dermatol. 133(10):2311\u20132314","journal-title":"J Investig Dermatol."},{"issue":"1","key":"8685_CR47","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.iac.2014.09.004","volume":"35","author":"J Savage","year":"2015","unstructured":"Savage J, Johns CB (2015) Food allergy: epidemiology and natural history. Immunol Allergy Clin N Am 35(1):45\u201359","journal-title":"Immunol Allergy Clin N Am"},{"key":"8685_CR48","doi-asserted-by":"crossref","unstructured":"Seltmann J, Roesner LM, von Hesler FW, Wittmann M, Werfel T. IL-33 impacts on the skin barrier by downregulating the expression of filaggrin. The Journal of allergy and clinical immunology. 2015;135(6):1659\u201361.e4","DOI":"10.1016\/j.jaci.2015.01.048"},{"key":"8685_CR49","unstructured":"AnaptysBio Initiates Multiple Ascending Dose Cohorts In ANB020 Phase 1 Clinical Trial. [press release]. July 6, 2016 2016"},{"issue":"1","key":"8685_CR50","first-page":"38","volume":"18","author":"R Jurakic Toncic","year":"2010","unstructured":"Jurakic Toncic R, Lipozencic J (2010) Role and significance of atopy patch test. Acta Dermatovenerol Croat : ADC 18(1):38\u201355","journal-title":"Acta Dermatovenerol Croat : ADC"},{"issue":"3","key":"8685_CR51","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1097\/MOO.0000000000000353","volume":"25","author":"WR Reisacher","year":"2017","unstructured":"Reisacher WR, Davison W (2017) Immunotherapy for food allergy. Curr Opin Otolaryngol Head Neck Surg 25(3):235\u2013241","journal-title":"Curr Opin Otolaryngol Head Neck Surg"},{"key":"8685_CR52","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/j.jconrel.2016.10.003","volume":"243","author":"PL Herve","year":"2016","unstructured":"Herve PL, Descamps D, Deloizy C, Dhelft V, Laubreton D, Bouguyon E et al (2016) Non-invasive epicutaneous vaccine against respiratory syncytial virus: preclinical proof of concept. J Control Release : Off J Control Release Soc 243:146\u2013159","journal-title":"J Control Release : Off J Control Release Soc"},{"issue":"4","key":"8685_CR53","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1111\/j.1365-2222.2009.03430.x","volume":"40","author":"L Mondoulet","year":"2010","unstructured":"Mondoulet L, Dioszeghy V, Ligouis M, Dhelft V, Dupont C, Benhamou PH (2010) Epicutaneous immunotherapy on intact skin using a new delivery system in a murine model of allergy. Clin Exp Allergy : J Br Soc Allergy Clin Immunol 40(4):659\u2013667","journal-title":"Clin Exp Allergy : J Br Soc Allergy Clin Immunol"},{"issue":"4","key":"8685_CR54","doi-asserted-by":"publisher","first-page":"1242","DOI":"10.1016\/j.jaci.2016.08.017","volume":"139","author":"SM Jones","year":"2017","unstructured":"Jones SM, Sicherer SH, Burks AW, Leung DY, Lindblad RW, Dawson P et al (2017) Epicutaneous immunotherapy for the treatment of peanut allergy in children and young adults. J Allergy Clin Immunol 139(4):1242\u201352.e9","journal-title":"J Allergy Clin Immunol"},{"issue":"2","key":"8685_CR55","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1016\/j.jaci.2016.08.029","volume":"139","author":"DA Ewald","year":"2017","unstructured":"Ewald DA, Noda S, Oliva M, Litman T, Nakajima S, Li X, Xu H, Workman CT, Scheipers P, Svitacheva N, Labuda T, Krueger JG, Su\u00e1rez-Fari\u00f1as M, Kabashima K, Guttman-Yassky E (2017) Major differences between human atopic dermatitis and murine models, as determined by using global transcriptomic profiling. J Allergy Clin Immunol 139(2):562\u2013571","journal-title":"J Allergy Clin Immunol"},{"issue":"4","key":"8685_CR56","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0018266","volume":"6","author":"WR Swindell","year":"2011","unstructured":"Swindell WR, Johnston A, Carbajal S, Han G, Wohn C, Lu J, Xing X, Nair RP, Voorhees JJ, Elder JT, Wang XJ, Sano S, Prens EP, DiGiovanni J, Pittelkow MR, Ward NL, Gudjonsson JE (2011) Genome-wide expression profiling of five mouse models identifies similarities and differences with human psoriasis. PLoS One 6(4):e18266","journal-title":"PLoS One"},{"issue":"3","key":"8685_CR57","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0058196","volume":"8","author":"SK Bromley","year":"2013","unstructured":"Bromley SK, Larson RP, Ziegler SF, Luster AD (2013) IL-23 induces atopic dermatitis-like inflammation instead of psoriasis-like inflammation in CCR2-deficient mice. PLoS One 8(3):e58196","journal-title":"PLoS One"},{"issue":"7","key":"8685_CR58","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1007\/BF00210634","volume":"74","author":"C Neumann","year":"1996","unstructured":"Neumann C, Gutgesell C, Fliegert F, Bonifer R, Herrmann F (1996) Comparative analysis of the frequency of house dust mite specific and nonspecific Th1 and Th2 cells in skin lesions and peripheral blood of patients with atopic dermatitis. J Mol Med(Berlin, Germany) 74(7):401\u2013406","journal-title":"J Mol Med(Berlin, Germany)"},{"issue":"4","key":"8685_CR59","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1111\/j.1365-2133.1996.tb03831.x","volume":"135","author":"M Gfesser","year":"1996","unstructured":"Gfesser M, Rakoski J, Ring J (1996) The disturbance of epidermal barrier function in atopy patch test reactions in atopic eczema. Br J Dermatol 135(4):560\u2013565","journal-title":"Br J Dermatol"},{"issue":"2","key":"8685_CR60","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1538\/expanim.61.77","volume":"61","author":"A Tanaka","year":"2012","unstructured":"Tanaka A, Amagai Y, Oida K, Matsuda H (2012) Recent findings in mouse models for human atopic dermatitis. Exp Anim 61(2):77\u201384","journal-title":"Exp Anim"},{"issue":"5","key":"8685_CR61","doi-asserted-by":"publisher","first-page":"1254","DOI":"10.1016\/j.jaci.2015.08.015","volume":"136","author":"S Noda","year":"2015","unstructured":"Noda S, Suarez-Farinas M, Ungar B, Kim SJ, de Guzman Strong C, Xu H et al (2015) The Asian atopic dermatitis phenotype combines features of atopic dermatitis and psoriasis with increased TH17 polarization. J Allergy Clin Immunol 136(5):1254\u20131264","journal-title":"J Allergy Clin Immunol"},{"issue":"2","key":"8685_CR62","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1016\/j.jaci.2013.04.046","volume":"132","author":"M Suarez-Farinas","year":"2013","unstructured":"Suarez-Farinas M, Dhingra N, Gittler J, Shemer A, Cardinale I, de Guzman Strong C et al (2013) Intrinsic atopic dermatitis shows similar TH2 and higher TH17 immune activation compared with extrinsic atopic dermatitis. J Allergy Clin Immunol 132(2):361\u2013370","journal-title":"J Allergy Clin Immunol"},{"issue":"6","key":"8685_CR63","doi-asserted-by":"publisher","first-page":"1639","DOI":"10.1016\/j.jaci.2016.07.013","volume":"138","author":"H Esaki","year":"2016","unstructured":"Esaki H, Brunner PM, Renert-Yuval Y, Czarnowicki T, Huynh T, Tran G, Lyon S, Rodriguez G, Immaneni S, Johnson DB, Bauer B, Fuentes-Duculan J, Zheng X, Peng X, Estrada YD, Xu H, de Guzman Strong C, Su\u00e1rez-Fari\u00f1as M, Krueger JG, Paller AS, Guttman-Yassky E (2016) Early-onset pediatric atopic dermatitis is TH2 but also TH17 polarized in skin. J Allergy Clin Immunol 138(6):1639\u20131651","journal-title":"J Allergy Clin Immunol"},{"issue":"6","key":"8685_CR64","doi-asserted-by":"publisher","first-page":"1723","DOI":"10.1016\/j.jaci.2017.04.004","volume":"139","author":"T Czarnowicki","year":"2017","unstructured":"Czarnowicki T, Krueger JG, Guttman-Yassky E (2017) Novel concepts of prevention and treatment of atopic dermatitis through barrier and immune manipulations with implications for the atopic march. J Allergy Clin Immunol 139(6):1723\u20131734","journal-title":"J Allergy Clin Immunol"},{"issue":"0","key":"8685_CR65","doi-asserted-by":"publisher","first-page":"1048","DOI":"10.1016\/j.jaci.2012.01.063","volume":"129","author":"S Nakajima","year":"2012","unstructured":"Nakajima S, Igyarto BZ, Honda T, Egawa G, Otsuka A, Hara-Chikuma M et al (2012) Langerhans cells are critical in epicutaneous sensitization with protein antigen via thymic stromal lymphopoietin receptor signaling. JAllergy Clin Immunol 129(0):1048\u201355.e6","journal-title":"JAllergy Clin Immunol"},{"issue":"5","key":"8685_CR66","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1016\/j.humimm.2009.02.003","volume":"70","author":"K Steinbrink","year":"2009","unstructured":"Steinbrink K, Mahnke K, Grabbe S, Enk AH, Jonuleit H (2009) Myeloid dendritic cell: from sentinel of immunity to key player of peripheral tolerance? Hum Immunol 70(5):289\u2013293","journal-title":"Hum Immunol"},{"issue":"1","key":"8685_CR67","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1111\/j.1365-2249.2010.04162.x","volume":"161","author":"N Novak","year":"2010","unstructured":"Novak N, Gros E, Bieber T, Allam JP (2010) Human skin and oral mucosal dendritic cells as \u2018good guys\u2019 and \u2018bad guys\u2019 in allergic immune responses. Clin Exp Immunol 161(1):28\u201333","journal-title":"Clin Exp Immunol"},{"key":"8685_CR68","unstructured":"Our innovative EPIT\u00ae mechanism of action may have the potential to offer compelling clinical benefits to patients suffering from food allergies. 2014 [Available from: https:\/\/www.dbv-technologies.com\/en\/epit\/moa ]"},{"issue":"5","key":"8685_CR69","doi-asserted-by":"publisher","first-page":"902","DOI":"10.1111\/bjd.14871","volume":"175","author":"R Bissonnette","year":"2016","unstructured":"Bissonnette R, Papp KA, Poulin Y, Gooderham M, Raman M, Mallbris L, Wang C, Purohit V, Mamolo C, Papacharalambous J, Ports WC (2016) Topical tofacitinib for atopic dermatitis: a phase IIa randomized trial. Br J Dermatol 175(5):902\u2013911","journal-title":"Br J Dermatol"}],"container-title":["Clinical Reviews in Allergy & Immunology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12016-018-8685-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12016-018-8685-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12016-018-8685-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,23]],"date-time":"2022-08-23T16:03:47Z","timestamp":1661270627000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12016-018-8685-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5,12]]},"references-count":69,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,2]]}},"alternative-id":["8685"],"URL":"https:\/\/doi.org\/10.1007\/s12016-018-8685-0","relation":{},"ISSN":["1080-0549","1559-0267"],"issn-type":[{"value":"1080-0549","type":"print"},{"value":"1559-0267","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,5,12]]},"assertion":[{"value":"12 May 2018","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"EGY is an employee of Mount Sinai and has received research funds (grants paid to the institution) from AbbVie, Celgene, Eli Lilly, Janssen, Medimmune\/AstraZeneca, Novartis, Pfizer, Regeneron, Vitae, Glenmark, Galderma, Asana, Innovaderm, Dermira, and UCB. EGY is also a consultant for Sanofi Aventis, Regeneron, Stiefel\/GlaxoSmithKline, MedImmune, Celgene, Anacor, AnaptysBio, Dermira, Galderma, Glenmark, Novartis, Pfizer, Vitae, Leo Pharma, AbbVie, Eli Lilly, Kyowa, Mitsubishi Tanabe, Asana Biosciences, and Promius. AL declares no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}